#oncology

[ follow ]
#funding

UK medtech startup 52North bags 5.7M funding - Silicon Canals

52North secured $6M in funding to enhance oncology urgent care pathways and advance its innovative products.

Resilience Raises $25M to Expand Remote Oncology Patient Monitoring

Resilience raised $25 million for oncology remote monitoring, expanding in Europe.

PhoreMost $12M Series B Financing to Advance Next-Gen Degrader Programs

PhoreMost has raised $12 million in Series B funding, advancing its pipeline for oncology and inflammatory diseases.
The company aims to move cancer treatment programs into preclinical development with this new funding.

UK medtech startup 52North bags 5.7M funding - Silicon Canals

52North secured $6M in funding to enhance oncology urgent care pathways and advance its innovative products.

Resilience Raises $25M to Expand Remote Oncology Patient Monitoring

Resilience raised $25 million for oncology remote monitoring, expanding in Europe.

PhoreMost $12M Series B Financing to Advance Next-Gen Degrader Programs

PhoreMost has raised $12 million in Series B funding, advancing its pipeline for oncology and inflammatory diseases.
The company aims to move cancer treatment programs into preclinical development with this new funding.
morefunding

My Traumatized Dog and I Had Trust Issues

The author reflects on the contrast between medical expertise and the emotional connection needed in healing.

A First-of-Its-Kind Explainable AI Model Detects Brain Cancer

A new study combines explainable AI with camouflage algorithms to improve brain cancer detection, representing a breakthrough at the intersection of neuroscience and oncology.
#cancer

The unknowns surrounding the mysterious rise of cancer in young adults

The rise of cancer in young adults is alarming, with nearly 80% increase in tumors under 50 years in the last 30 years.

OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI | TechCrunch

OneCell Diagnostics aims to revolutionize cancer recurrence detection through innovative blood-based biopsy techniques.

The unknowns surrounding the mysterious rise of cancer in young adults

The rise of cancer in young adults is alarming, with nearly 80% increase in tumors under 50 years in the last 30 years.

OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI | TechCrunch

OneCell Diagnostics aims to revolutionize cancer recurrence detection through innovative blood-based biopsy techniques.
morecancer
#cancer-treatment

Amazing' trial shows drug combination stops lung cancer advancing for longer

A new drug combination significantly extends progression-free survival in advanced lung cancer patients compared to standard treatment.

Tak Mak, immunologist: The immune system is the orchestra for most of life's symphonies'

Immunotherapy represents a revolutionary advancement in cancer treatment, surpassing traditional methods like chemotherapy and radiotherapy in efficacy.

Top Cancer Hospitals for Comprehensive Treatment in 2024

Selecting the right hospital for cancer treatment involves considering various factors like quality of care and advanced treatment technology.

Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovation

Cancer treatment has evolved significantly over the past 25 years, enabling more targeted therapies and improved patient outcomes.

Amazing' trial shows drug combination stops lung cancer advancing for longer

A new drug combination significantly extends progression-free survival in advanced lung cancer patients compared to standard treatment.

Tak Mak, immunologist: The immune system is the orchestra for most of life's symphonies'

Immunotherapy represents a revolutionary advancement in cancer treatment, surpassing traditional methods like chemotherapy and radiotherapy in efficacy.

Top Cancer Hospitals for Comprehensive Treatment in 2024

Selecting the right hospital for cancer treatment involves considering various factors like quality of care and advanced treatment technology.

Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovation

Cancer treatment has evolved significantly over the past 25 years, enabling more targeted therapies and improved patient outcomes.
morecancer-treatment

Pharmacologic restoration of GTP hydrolysis by mutant RAS

Tri-complex inhibitors can stimulate GTP hydrolysis in RAS mutants, enhancing therapeutic effectiveness for specific mutations.

Breakthrough by William Pao review the drugs do work

Creative innovation in drug development becomes a transformative force in medicine, driven by personal dedication and often serendipitous discoveries.
#health

SoftBank forms AI healthcare JV in Japan with Tempus | TechCrunch

SoftBank Group and Tempus form joint venture in Japan to develop AI-powered personalized medical services, starting with oncology.

When I delivered the worst of news to my dying patient, she cried but not about her prognosis | Ranjana Srivastava

The article reflects on a compassionate yet painful meeting between a doctor and a terminally ill patient, highlighting the emotional toll of delivering bad news.

SoftBank forms AI healthcare JV in Japan with Tempus | TechCrunch

SoftBank Group and Tempus form joint venture in Japan to develop AI-powered personalized medical services, starting with oncology.

When I delivered the worst of news to my dying patient, she cried but not about her prognosis | Ranjana Srivastava

The article reflects on a compassionate yet painful meeting between a doctor and a terminally ill patient, highlighting the emotional toll of delivering bad news.
morehealth

New cervical cancer treatment regime cuts risk of dying from disease by 40%'

New treatment for cervical cancer reduces risk of dying by 40%, marking a significant breakthrough in the last 25 years of medical research.
#cancer-research

Immunotherapy achieves remarkable survival rates in a handful of tumors

Immunotherapy has significantly improved prognosis and survival rates for patients with metastatic melanoma over the past 15 years.

New Chief of Division of Hematology and Oncology Named - News Center

Hidayatullah G. Munshi has been appointed as chief of the Division of Hematology and Oncology, effective October 15.

Immunotherapy achieves remarkable survival rates in a handful of tumors

Immunotherapy has significantly improved prognosis and survival rates for patients with metastatic melanoma over the past 15 years.

New Chief of Division of Hematology and Oncology Named - News Center

Hidayatullah G. Munshi has been appointed as chief of the Division of Hematology and Oncology, effective October 15.
morecancer-research
#breast-cancer

V. Craig Jordan, Who Discovered a Key Breast Cancer Drug, Dies at 76

V. Craig Jordan's discovery of using tamoxifen to block breast cancer growth revolutionized oncology and saved many lives.

Men get breast cancer, too. But they can't always access new drugs | CBC News

Warren Kotler has outlived his terminal cancer prognosis through treatment and lifestyle changes, exemplifying resilience amid uncertainty about future treatment efficacy.

V. Craig Jordan, Who Discovered a Key Breast Cancer Drug, Dies at 76

V. Craig Jordan's discovery of using tamoxifen to block breast cancer growth revolutionized oncology and saved many lives.

Men get breast cancer, too. But they can't always access new drugs | CBC News

Warren Kotler has outlived his terminal cancer prognosis through treatment and lifestyle changes, exemplifying resilience amid uncertainty about future treatment efficacy.
morebreast-cancer

SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition - MedCity News

Ipsen is focused on expanding its oncology portfolio via acquisitions, now marred by insider trading allegations against an employee.
Dishant Gupta is charged with insider trading connected to Ipsen's acquisition of Epizyme due to his knowledge of non-public information.

Gasdermin D-mediated metabolic crosstalk promotes tissue repair - Nature

Interdisciplinary collaboration in medical research enhances innovation and problem-solving capabilities.

3 Penny Stocks to Buy With $500

Penny stocks can yield significant returns but come with high risk; only invest what you can afford to lose.

How to Find the Right Oncologist for You

Choosing the right oncologist is crucial for cancer treatment outcomes and patient satisfaction.

AI assistance for planning cancer treatment

AI algorithms are aiding oncologists in predicting responders to immunotherapy, improving treatment outcomes.

Study Identifies Disparities in End-of-Life Care for Lung Cancer Patients - News Center

Racial and ethnic minorities with lung cancer experience higher intensity of end-of-life care compared to white patients.

Resveratrol: A Ray of Hope in the Battle Against Oral Cancer

Resveratrol shows promise in combating oral cancer.

New scanner can diagnose cancer in five minutes instead of 30

A new 8 million scanner at the Royal Free Hospital in north London can diagnose cancer in just five minutes, compared to the usual half-an-hour.
The scanner is 30 times more powerful than standard machines, exposes patients to less radiation, and provides oncologists with more detailed information for more effective treatment.
[ Load more ]